|
BQS-Bundesauswertung
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Hüftgelenknahe
Femurfraktur |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Übersicht Qualitätsindikatoren |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Übersicht Qualitätsindikatoren |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-
Pertrochantäre Fraktur - |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ergebnis |
|
Ergebnis |
|
Referenz- |
|
|
|
|
|
Qualitätsindikator |
|
|
|
|
|
|
|
|
|
|
Anzahl |
|
|
|
% |
|
|
bereich |
|
Seite |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QI 2.1: Präoperative Verweildauer |
|
|
|
3.720 / 44.967 |
|
|
8,27% |
nicht definiert |
|
1.40 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QI 2.2: Perioperative |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Antibiotikaprophylaxe |
|
|
|
|
|
|
42.292 / 44.967 |
|
|
94,05% |
|
|
>= 95% |
|
1.42 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QI 2.3: Gehfähigkeit bei Entlassung |
|
|
|
8.660 / 38.193 |
|
|
22,67% |
nicht definiert |
|
1.44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QI 2.4: Gefäßläsion oder |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nervenschaden |
|
|
|
|
|
|
|
|
69 / 44.967 |
|
|
0,15% |
|
|
<= 2% |
|
1.46 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QI 2.5: Implantatfehllage, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Implantatdislokation oder Fraktur |
|
|
|
|
780 / 44.967 |
|
|
1,73% |
|
|
<= 2% |
|
1.48 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QI 2.6: Endoprothesenluxation |
|
|
|
|
|
60 / 3.291 |
|
|
1,82% |
|
|
<= 5% |
|
1.50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QI 2.7: Postoperative Wundinfektion |
|
|
|
|
787 / 44.967 |
|
|
1,75% |
|
|
<= 5% |
|
1.52 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QI 2.8: Wundhämatome/ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nachblutungen |
|
|
|
|
|
|
|
|
1.210 / 44.967 |
|
|
2,69% |
|
|
<= 12% |
|
1.60 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QI 2.9: Allgemeine postoperative |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Komplikationen |
|
|
|
|
|
|
|
3.307 / 44.967 |
|
|
7,35% |
|
<= 18,4% |
|
1.63 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QI 2.10: Reinterventionen wegen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Komplikation |
|
|
|
|
|
|
|
|
1.758 / 44.967 |
|
|
3,91% |
|
|
<= 12% |
|
1.65 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QI 2.11: Letalität |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bei Patienten mit osteosynthetischer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Versorgung bei pertrochantärer Fraktur |
|
|
2.121 / 41.042 |
|
|
5,17% |
|
<= 13,0% |
|
1.67 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bei Patienten mit endoprothetischer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Versorgung bei pertrochantärer Fraktur |
|
|
|
180 / 3.291 |
|
|
5,47% |
|
|
<= x% |
|
1.67 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bei Patienten mit ASA 1 bis 2 |
|
|
|
|
|
|
148 / 12.259 |
|
|
1,21% |
nicht definiert |
|
1.70 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bei Patienten mit ASA 3 |
|
|
|
|
|
|
1.392 / 28.679 |
|
|
4,85% |
nicht definiert |
|
1.70 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
© BQS 2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30.05.2007 / 2006 - D4836-L39443-P19487 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
